BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,864,918 | -20.1% | 605,854 | -3.5% | 0.36% | -17.7% |
| Q2 2023 | $28,602,234 | -6.5% | 627,793 | -16.8% | 0.43% | -12.5% |
| Q1 2023 | $30,599,749 | -18.4% | 754,432 | +2.6% | 0.50% | -23.1% |
| Q4 2022 | $37,494,000 | -4.3% | 735,609 | +1.1% | 0.64% | -10.5% |
| Q3 2022 | $39,192,000 | -7.9% | 727,668 | +9.9% | 0.72% | -2.0% |
| Q2 2022 | $42,533,000 | -17.3% | 662,203 | -0.2% | 0.74% | +0.5% |
| Q1 2022 | $51,450,000 | -8.6% | 663,534 | +1.2% | 0.73% | -6.3% |
| Q4 2021 | $56,286,000 | +8.0% | 655,703 | +1.2% | 0.78% | -5.2% |
| Q3 2021 | $52,123,000 | +0.2% | 648,049 | +0.3% | 0.82% | -1.0% |
| Q2 2021 | $52,033,000 | -4.7% | 646,379 | -0.2% | 0.83% | -12.2% |
| Q1 2021 | $54,622,000 | +4.5% | 647,637 | -0.6% | 0.95% | +2.5% |
| Q4 2020 | $52,290,000 | +2.5% | 651,672 | +2.7% | 0.92% | -7.2% |
| Q3 2020 | $51,039,000 | -3.6% | 634,656 | +3.2% | 1.00% | -14.6% |
| Q2 2020 | $52,972,000 | +8.4% | 615,237 | +2.2% | 1.17% | -7.2% |
| Q1 2020 | $48,883,000 | +10.6% | 602,076 | +13.9% | 1.26% | +26.0% |
| Q4 2019 | $44,189,000 | -4.5% | 528,456 | -0.1% | 1.00% | -12.6% |
| Q3 2019 | $46,276,000 | +6.1% | 529,047 | -0.6% | 1.14% | +4.8% |
| Q2 2019 | $43,607,000 | +0.7% | 532,448 | +0.0% | 1.09% | -2.8% |
| Q1 2019 | $43,284,000 | +17.5% | 532,333 | -4.9% | 1.12% | +7.4% |
| Q4 2018 | $36,834,000 | -15.3% | 559,617 | -0.8% | 1.05% | -3.9% |
| Q3 2018 | $43,480,000 | +4.3% | 564,013 | -0.1% | 1.09% | -4.1% |
| Q2 2018 | $41,692,000 | +13.1% | 564,625 | -0.3% | 1.14% | +11.2% |
| Q1 2018 | $36,852,000 | +14.3% | 566,604 | +13.6% | 1.02% | +13.7% |
| Q4 2017 | $32,230,000 | +2.9% | 498,605 | -0.1% | 0.90% | -4.5% |
| Q3 2017 | $31,332,000 | +3.3% | 499,311 | -0.3% | 0.94% | +0.1% |
| Q2 2017 | $30,333,000 | +16.4% | 501,036 | -0.3% | 0.94% | +10.1% |
| Q1 2017 | $26,063,000 | +15.3% | 502,564 | -1.4% | 0.85% | +7.4% |
| Q4 2016 | $22,605,000 | -9.2% | 509,809 | -2.5% | 0.79% | -9.8% |
| Q3 2016 | $24,896,000 | +0.1% | 523,023 | -4.9% | 0.88% | -0.9% |
| Q2 2016 | $24,869,000 | +1.8% | 549,946 | -7.5% | 0.89% | +1.1% |
| Q1 2016 | $24,424,000 | +5.5% | 594,556 | -2.0% | 0.88% | +8.7% |
| Q4 2015 | $23,144,000 | +9.4% | 606,656 | -5.8% | 0.81% | +4.3% |
| Q3 2015 | $21,151,000 | -52.8% | 643,876 | +0.4% | 0.78% | -50.8% |
| Q2 2015 | $44,852,000 | -29.8% | 641,380 | -31.3% | 1.58% | -28.1% |
| Q1 2015 | $63,932,000 | -5.6% | 933,316 | +1.0% | 2.19% | -5.4% |
| Q4 2014 | $67,720,000 | +2.8% | 924,001 | +0.7% | 2.32% | -2.5% |
| Q3 2014 | $65,875,000 | +0.7% | 917,865 | +1.5% | 2.38% | -1.6% |
| Q2 2014 | $65,394,000 | -1.4% | 904,483 | +0.3% | 2.42% | -2.1% |
| Q1 2014 | $66,348,000 | +6.0% | 901,710 | +0.2% | 2.47% | +5.5% |
| Q4 2013 | $62,609,000 | +12.4% | 900,205 | +6.1% | 2.34% | +3.0% |
| Q3 2013 | $55,718,000 | -4.5% | 848,200 | +0.7% | 2.27% | -6.7% |
| Q2 2013 | $58,369,000 | – | 842,630 | – | 2.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |